These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 9781657)
1. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium. Ioffe OB; Papadimitriou JC; Drachenberg CB Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657 [TBL] [Abstract][Full Text] [Related]
2. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance]. Hu WF; Liu MQ; Zhao Q Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611 [TBL] [Abstract][Full Text] [Related]
4. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology. Apostolou G; Apostolou N; Biteli M; Kavantzas N; Patsouris E; Athanassiadou P Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350 [TBL] [Abstract][Full Text] [Related]
5. Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications. Risberg B; Karlsson K; Abeler V; Lagrelius A; Davidson B; Karlsson MG Int J Gynecol Pathol; 2002 Apr; 21(2):155-60. PubMed ID: 11917225 [TBL] [Abstract][Full Text] [Related]
6. Cellular apoptosis susceptibility gene expression in endometrial carcinoma: correlation with Bcl-2, Bax, and caspase-3 expression and outcome. Peiró G; Diebold J; Baretton GB; Kimmig R; Löhrs U Int J Gynecol Pathol; 2001 Oct; 20(4):359-67. PubMed ID: 11603220 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index. Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031 [TBL] [Abstract][Full Text] [Related]
8. Proliferative and apoptotic changes in the healthy canine endometrium and in cystic endometrial hyperplasia. Reusche N; Beineke A; Urhausen C; Beyerbach M; Schmicke M; Kramer S; Günzel-Apel AR Theriogenology; 2018 Jul; 114():14-24. PubMed ID: 29574305 [TBL] [Abstract][Full Text] [Related]
9. The patterns of expression of an apoptosis-related CK18 neoepitope, the bcl-2 proto-oncogene, and the Ki67 proliferation marker in normal, hyperplastic, and malignant endometrium. Morsi HM; Leers MP; Jäger W; Björklund V; Radespiel-Tröger M; el Kabarity H; Nap M; Lang N Int J Gynecol Pathol; 2000 Apr; 19(2):118-26. PubMed ID: 10782407 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium. Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680 [TBL] [Abstract][Full Text] [Related]
11. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901 [TBL] [Abstract][Full Text] [Related]
12. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival. Pich A; Margaria E; Chiusa L J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma. Vaskivuo TE; Stenbäck F; Tapanainen JS Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915 [TBL] [Abstract][Full Text] [Related]
14. Comparison of B-cell lymphoma 2 (BCL-2) expression in disordered proliferative endometrium and simple endometrial hyperplasia. Ghorbanniadelavar Z; Jalali Nadoushan M; Soltanipur M Rev Esp Patol; 2024; 57(4):265-272. PubMed ID: 39393894 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of invasive squamous cell carcinoma and verrucous carcinoma of the oral cavity: expression of bcl-2, p53, and Her-2/neu, and indexes of cell turnover. Drachenberg CB; Blanchaert R; Ioffe OB; Ord RA; Papadimitriou JC Cancer Detect Prev; 1997; 21(6):483-9. PubMed ID: 9398988 [TBL] [Abstract][Full Text] [Related]
16. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features. Yu CG; Jiang XY; Li B; Gan L; Huang JF Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913 [TBL] [Abstract][Full Text] [Related]
17. bcl-2 protein expression in endometrial carcinoma: the lack of correlation with p53. Miturski R; Semczuk A; Tomaszewski J; Jakowicki J Cancer Lett; 1998 Nov; 133(1):63-9. PubMed ID: 9929161 [TBL] [Abstract][Full Text] [Related]
18. [Expression of p53, Ki-67, bcl-2, c-erb-2, estrogen, and progesterone receptors in endometrial cancer]. Pilka R; Mícková I; Lubuský M; Dusková M; Rícánková M; Kudela M Ceska Gynekol; 2008 Jul; 73(4):222-7. PubMed ID: 18711961 [TBL] [Abstract][Full Text] [Related]
19. Expression of p53, Bcl-2 and Bax in endometrial carcinoma, endometrial hyperplasia and normal endometrium: a histopathological study. Mirakhor Samani S; Ezazi Bojnordi T; Zarghampour M; Merat S; Fouladi DF J Obstet Gynaecol; 2018 Oct; 38(7):999-1004. PubMed ID: 29560769 [TBL] [Abstract][Full Text] [Related]